The Commission is confident that the EU pharmaceutical industry will avoid a new 100% tariff rate announced by US President Donald Trump on Thursday and believes the sector will remain covered by the trade agreement it concluded in July with the US, establishing a 15% tariff cap on EU imports.
“This clear all-inclusive 15% tariff ceiling for EU exports represents an insurance policy that no higher tariffs will emerge for European economic operators. The EU is the only trade partner to achieve this outcome with the US,” EU Commission deputy spokesperson Olof Gill said on Friday.
